Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals shares declined 8.57 percent on volume of 437,340 shares traded Monday to close at $5.44 a share. The company announced that they will release results for the fourth quarter and full year 2012 on Wednesday, March 13th.
Going forward ... (see research report)








